Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2026-01-01 @ 3:56 PM
Study NCT ID:
NCT05781958
Status:
UNKNOWN
Last Update Posted:
2023-11-02
First Post:
2023-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICC
Sponsor:
Shen Feng
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
EHBHKY2022-H039-P001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None